Navigation Links
Targeted therapeutics for colon cancer to be presented at AACR meeting
Date:4/3/2012

(Boston) - Anurag Singh, PhD, assistant professor in the Department of Pharmacology and Experimental Therapeutics at Boston University School of Medicine has been invited to present his recent work on targeted therapeutics for colon cancer at the American Association of Cancer Research Annual Meeting in Chicago, IL. Singh's seminar, scheduled for Tuesday April 3rd, will be featured in the "Late-Breaking Abstracts Mini-Symposium". This highlights recent and provocative groundbreaking research in cancer biology.

Over one million cases of colon cancer are diagnosed worldwide each year resulting in approximately 600,000 deaths annually. Disease-causing mutations in the KRAS gene are found in over half of these cases. In the United States, colon cancer patients are routinely genotyped for KRAS gene mutations and those with mutations are excluded from receiving novel "targeted" therapeutic agents due to a lack of clinical benefit. Thus, patients with KRAS gene mutations are faced with very limited therapeutic options and are subsequently given very poor clinical prognoses.

Singh and his colleagues have identified a network of genes that are hyper-activated in KRAS mutant colon cancers. Within this network is a gene called MAP3K7 or TAK1, which plays a very critical role in promoting colon cancer disease progression. Pharmacological inhibition of TAK1 results in strong killing of affected tumor cells, with minimal effects in "normal" non-mutated cells. "These findings raise the possibility that anti-TAK1 agents could provide the basis for "personalized" medicine in patients with highly aggressive KRAS mutant colon cancers," said Singh. Efforts are now underway to identify clinically efficacious TAK1 inhibitors.


'/>"/>

Contact: Gina DiGravio
gina.digravio@bmc.org
617-638-8480
Boston University Medical Center
Source:Eurekalert

Page: 1

Related medicine news :

1. 2 targeted therapies act against Ewings sarcoma tumors
2. Targeted drug helps leukemia patients who do not benefit from initial therapy
3. Wayne State proves targeted tumor freezing therapy increases ovarian cancer survival
4. Rowley to receive Japan Prize for her role in the development of targeted cancer therapy
5. Targeted therapy extends progression-free survival of patients with advanced ovarian cancer
6. Targeted Radiation for Breast Cancer May Be Overused: Study
7. Targeted Radiation May Not Be Better for Breast Cancer
8. Targeted Drugs, Lung CT Screening Top Cancer Advances in 2011
9. More Targeted Treatments Key to Progress in War on Cancer: Report
10. First-of-its-kind study creates new tool for targeted cancer drug development
11. Research involving thyroid hormone lays foundation for more targeted drug development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... ... non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a method ... —Johnson is one of the first doctors to perform the treatment. Orthobiologics are ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June 14 ... The article goes on to state that individuals are now more comfortable seeking to ... operations such as calf and cheek reduction. The Los Angeles area medical group, Beverly ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her son ... lash out at his family verbally and physically. , “When something upset him, he couldn’t ... would use it. He would throw rocks at my other children and say he was ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Dr. Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile ... orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can ...
(Date:6/24/2016)... ... ... People across the U.S. are sharpening their pencils and honing their writing skills ... patients and their families pay tribute to a genetic counselor by nominating him or ... Counselors (NSGC) Annual Education Conference (AEC) this September. , In April, Genome magazine ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... 2022" report to their offering. ... with kidney failure, it replaces the function of kidneys by ... and thus the treatment helps to keep the patient body,s ... Increasing number of ESRD patients & substantial healthcare ...
Breaking Medicine Technology: